Health Care & Life Sciences » Biotechnology | D. Western Therapeutics Institute Inc.

D. Western Therapeutics Institute Inc. | Income Statement

Fiscal year is January-December. All values JPY Thousands.
2013
2014
2015
2016
2017
Sales/Revenue
80,000.00
80,025.00
61,818.00
168,002.00
254,028.00
Cost of Goods Sold (COGS) incl. D&A
-
2,184.00
16,045.00
23,229.00
52,422.00
Gross Income
-
77,841.00
45,773.00
144,773.00
201,606.00
SG&A Expense
286,579.00
274,796.00
336,296.00
470,305.00
835,313.00
EBIT
208,790.00
196,955.00
290,523.00
325,532.00
633,707.00
Unusual Expense
-
-
-
-
1,038,343.00
Non Operating Income/Expense
13,064.00
2,205.00
8,617.00
18,211.00
70,981.00
Interest Expense
-
-
-
-
5,402.00
Pretax Income
221,214.00
191,685.00
295,372.00
304,463.00
1,605,843.00
Income Tax
957.00
957.00
1,099.00
1,759.00
1,840.00
Consolidated Net Income
222,171.00
192,642.00
296,471.00
306,223.00
1,607,683.00
Net Income
222,171.00
192,642.00
296,471.00
253,515.00
1,563,498.00
Net Income After Extraordinaries
222,171.00
192,642.00
296,471.00
253,515.00
1,563,498.00
Net Income Available to Common
222,171.00
192,642.00
296,471.00
253,514.00
1,563,497.00
EPS (Basic)
9.79
8.47
12.99
10.46
59.89
Basic Shares Outstanding
22,695.90
22,746.50
22,817.00
24,234.50
26,105.70
EPS (Diluted)
9.79
8.47
12.99
10.46
59.89
Diluted Shares Outstanding
22,695.90
22,746.50
22,817.00
24,234.50
26,105.70
EBITDA
206,579.00
194,771.00
274,478.00
307,975.00
588,589.00
Non-Operating Interest Income
640.00
3,065.00
3,768.00
2,856.00
628.00
Minority Interest Expense
-
-
-
52,708.00
44,185.00

About D. Western Therapeutics Institute

View Profile
Address
CK21 Hirokoji-Fushimi Building, 7/F
Nagoya Aichi 460
Japan
Employees -
Website http://www.dwti.co.jp
Updated 09/14/2018
D. Western Therapeutics Institute, Inc. engages in the research and development of pharmaceutical drugs. Its products include ophthalmic solution and agents for anti-platelet and anti-glaucoma.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.